Multispecific agents for treatment of cancer
The invention provides multispecific agents having one arm binding CD47, and a second arm binding to CD24. The invention also provides multispecific agents having one arm binding to SIRPa and a second arm binding to siglec-10.
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
18.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides multispecific agents having one arm binding CD47, and a second arm binding to CD24. The invention also provides multispecific agents having one arm binding to SIRPa and a second arm binding to siglec-10. |
---|---|
Bibliography: | Application Number: AU20200245486 |